The global market for Stroke Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Stroke Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stroke Therapeutics.

The Stroke Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stroke Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stroke Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Stroke Therapeutics Market Report

Report Metric	Details
Report Name	Stroke Therapeutics Market
CAGR	5%
Segment by Type	Intravenous Injection Oral Others
Segment by Application	Ischemic Stroke Hemorrhagic Stroke Transient Ischemic Attack
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Cordis, Boston Scientific, Siemens, Genentech, Koninklijke Philips, Medtronic, GE Healthcare, Stryker, Merck, Zocere, Inc., Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, AXONIS Therapeutics , Inc., NovaGo Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stroke Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Stroke Therapeutics Market report?

Ans: The main players in the Stroke Therapeutics Market are Abbott Laboratories, Cordis, Boston Scientific, Siemens, Genentech, Koninklijke Philips, Medtronic, GE Healthcare, Stryker, Merck, Zocere, Inc., Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, AXONIS Therapeutics , Inc., NovaGo Therapeutics

What are the Application segmentation covered in the Stroke Therapeutics Market report?

Ans: The Applications covered in the Stroke Therapeutics Market report are Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack

What are the Type segmentation covered in the Stroke Therapeutics Market report?

Ans: The Types covered in the Stroke Therapeutics Market report are Intravenous Injection, Oral, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stroke Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intravenous Injection

1.2.3 Oral

1.2.4 Others

1.3 Market by Application

1.3.1 Global Stroke Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Ischemic Stroke

1.3.3 Hemorrhagic Stroke

1.3.4 Transient Ischemic Attack

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Stroke Therapeutics Market Perspective (2020-2031)

2.2 Global Stroke Therapeutics Growth Trends by Region

2.2.1 Global Stroke Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Stroke Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Stroke Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Stroke Therapeutics Market Dynamics

2.3.1 Stroke Therapeutics Industry Trends

2.3.2 Stroke Therapeutics Market Drivers

2.3.3 Stroke Therapeutics Market Challenges

2.3.4 Stroke Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Stroke Therapeutics Players by Revenue

3.1.1 Global Top Stroke Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Stroke Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Stroke Therapeutics Revenue

3.4 Global Stroke Therapeutics Market Concentration Ratio

3.4.1 Global Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stroke Therapeutics Revenue in 2024

3.5 Global Key Players of Stroke Therapeutics Head office and Area Served

3.6 Global Key Players of Stroke Therapeutics, Product and Application

3.7 Global Key Players of Stroke Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Stroke Therapeutics Breakdown Data by Type

4.1 Global Stroke Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Stroke Therapeutics Forecasted Market Size by Type (2026-2031)

5 Stroke Therapeutics Breakdown Data by Application

5.1 Global Stroke Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Stroke Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Stroke Therapeutics Market Size (2020-2031)

6.2 North America Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Stroke Therapeutics Market Size by Country (2020-2025)

6.4 North America Stroke Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Stroke Therapeutics Market Size (2020-2031)

7.2 Europe Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Stroke Therapeutics Market Size by Country (2020-2025)

7.4 Europe Stroke Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Stroke Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Stroke Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Stroke Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Stroke Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Stroke Therapeutics Market Size (2020-2031)

9.2 Latin America Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Stroke Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Stroke Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Stroke Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Stroke Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Stroke Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Stroke Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Stroke Therapeutics Introduction

11.1.4 Abbott Laboratories Revenue in Stroke Therapeutics Business (2020-2025)

11.1.5 Abbott Laboratories Recent Development

11.2 Cordis

11.2.1 Cordis Company Details

11.2.2 Cordis Business Overview

11.2.3 Cordis Stroke Therapeutics Introduction

11.2.4 Cordis Revenue in Stroke Therapeutics Business (2020-2025)

11.2.5 Cordis Recent Development

11.3 Boston Scientific

11.3.1 Boston Scientific Company Details

11.3.2 Boston Scientific Business Overview

11.3.3 Boston Scientific Stroke Therapeutics Introduction

11.3.4 Boston Scientific Revenue in Stroke Therapeutics Business (2020-2025)

11.3.5 Boston Scientific Recent Development

11.4 Siemens

11.4.1 Siemens Company Details

11.4.2 Siemens Business Overview

11.4.3 Siemens Stroke Therapeutics Introduction

11.4.4 Siemens Revenue in Stroke Therapeutics Business (2020-2025)

11.4.5 Siemens Recent Development

11.5 Genentech

11.5.1 Genentech Company Details

11.5.2 Genentech Business Overview

11.5.3 Genentech Stroke Therapeutics Introduction

11.5.4 Genentech Revenue in Stroke Therapeutics Business (2020-2025)

11.5.5 Genentech Recent Development

11.6 Koninklijke Philips

11.6.1 Koninklijke Philips Company Details

11.6.2 Koninklijke Philips Business Overview

11.6.3 Koninklijke Philips Stroke Therapeutics Introduction

11.6.4 Koninklijke Philips Revenue in Stroke Therapeutics Business (2020-2025)

11.6.5 Koninklijke Philips Recent Development

11.7 Medtronic

11.7.1 Medtronic Company Details

11.7.2 Medtronic Business Overview

11.7.3 Medtronic Stroke Therapeutics Introduction

11.7.4 Medtronic Revenue in Stroke Therapeutics Business (2020-2025)

11.7.5 Medtronic Recent Development

11.8 GE Healthcare

11.8.1 GE Healthcare Company Details

11.8.2 GE Healthcare Business Overview

11.8.3 GE Healthcare Stroke Therapeutics Introduction

11.8.4 GE Healthcare Revenue in Stroke Therapeutics Business (2020-2025)

11.8.5 GE Healthcare Recent Development

11.9 Stryker

11.9.1 Stryker Company Details

11.9.2 Stryker Business Overview

11.9.3 Stryker Stroke Therapeutics Introduction

11.9.4 Stryker Revenue in Stroke Therapeutics Business (2020-2025)

11.9.5 Stryker Recent Development

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Stroke Therapeutics Introduction

11.10.4 Merck Revenue in Stroke Therapeutics Business (2020-2025)

11.10.5 Merck Recent Development

11.11 Zocere, Inc.

11.11.1 Zocere, Inc. Company Details

11.11.2 Zocere, Inc. Business Overview

11.11.3 Zocere, Inc. Stroke Therapeutics Introduction

11.11.4 Zocere, Inc. Revenue in Stroke Therapeutics Business (2020-2025)

11.11.5 Zocere, Inc. Recent Development

11.12 Acticor Biotech

11.12.1 Acticor Biotech Company Details

11.12.2 Acticor Biotech Business Overview

11.12.3 Acticor Biotech Stroke Therapeutics Introduction

11.12.4 Acticor Biotech Revenue in Stroke Therapeutics Business (2020-2025)

11.12.5 Acticor Biotech Recent Development

11.13 DiaMedica Therapeutics

11.13.1 DiaMedica Therapeutics Company Details

11.13.2 DiaMedica Therapeutics Business Overview

11.13.3 DiaMedica Therapeutics Stroke Therapeutics Introduction

11.13.4 DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)

11.13.5 DiaMedica Therapeutics Recent Development

11.14 Lumosa Therapeutics

11.14.1 Lumosa Therapeutics Company Details

11.14.2 Lumosa Therapeutics Business Overview

11.14.3 Lumosa Therapeutics Stroke Therapeutics Introduction

11.14.4 Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)

11.14.5 Lumosa Therapeutics Recent Development

11.15 AXONIS Therapeutics , Inc.

11.15.1 AXONIS Therapeutics , Inc. Company Details

11.15.2 AXONIS Therapeutics , Inc. Business Overview

11.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Introduction

11.15.4 AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2020-2025)

11.15.5 AXONIS Therapeutics , Inc. Recent Development

11.16 NovaGo Therapeutics

11.16.1 NovaGo Therapeutics Company Details

11.16.2 NovaGo Therapeutics Business Overview

11.16.3 NovaGo Therapeutics Stroke Therapeutics Introduction

11.16.4 NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2020-2025)

11.16.5 NovaGo Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

DiaMedica Therapeutics

Lumosa Therapeutics

AXONIS Therapeutics , Inc.

List of Tables

Table 1. Global Stroke Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intravenous Injection

Table 3. Key Players of Oral

Table 4. Key Players of Others

Table 5. Global Stroke Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Stroke Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Stroke Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Stroke Therapeutics Market Share by Region (2020-2025)

Table 9. Global Stroke Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Stroke Therapeutics Market Share by Region (2026-2031)

Table 11. Stroke Therapeutics Market Trends

Table 12. Stroke Therapeutics Market Drivers

Table 13. Stroke Therapeutics Market Challenges

Table 14. Stroke Therapeutics Market Restraints

Table 15. Global Stroke Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Stroke Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2024)

Table 18. Ranking of Global Top Stroke Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Stroke Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Stroke Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Stroke Therapeutics, Product and Application

Table 22. Global Key Players of Stroke Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Stroke Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Stroke Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Stroke Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Stroke Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Stroke Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Stroke Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Stroke Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Stroke Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Stroke Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Stroke Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Stroke Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Stroke Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Stroke Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Stroke Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Abbott Laboratories Company Details

Table 48. Abbott Laboratories Business Overview

Table 49. Abbott Laboratories Stroke Therapeutics Product

Table 50. Abbott Laboratories Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Abbott Laboratories Recent Development

Table 52. Cordis Company Details

Table 53. Cordis Business Overview

Table 54. Cordis Stroke Therapeutics Product

Table 55. Cordis Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Cordis Recent Development

Table 57. Boston Scientific Company Details

Table 58. Boston Scientific Business Overview

Table 59. Boston Scientific Stroke Therapeutics Product

Table 60. Boston Scientific Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Boston Scientific Recent Development

Table 62. Siemens Company Details

Table 63. Siemens Business Overview

Table 64. Siemens Stroke Therapeutics Product

Table 65. Siemens Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Siemens Recent Development

Table 67. Genentech Company Details

Table 68. Genentech Business Overview

Table 69. Genentech Stroke Therapeutics Product

Table 70. Genentech Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Genentech Recent Development

Table 72. Koninklijke Philips Company Details

Table 73. Koninklijke Philips Business Overview

Table 74. Koninklijke Philips Stroke Therapeutics Product

Table 75. Koninklijke Philips Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Koninklijke Philips Recent Development

Table 77. Medtronic Company Details

Table 78. Medtronic Business Overview

Table 79. Medtronic Stroke Therapeutics Product

Table 80. Medtronic Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Medtronic Recent Development

Table 82. GE Healthcare Company Details

Table 83. GE Healthcare Business Overview

Table 84. GE Healthcare Stroke Therapeutics Product

Table 85. GE Healthcare Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 86. GE Healthcare Recent Development

Table 87. Stryker Company Details

Table 88. Stryker Business Overview

Table 89. Stryker Stroke Therapeutics Product

Table 90. Stryker Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 91. Stryker Recent Development

Table 92. Merck Company Details

Table 93. Merck Business Overview

Table 94. Merck Stroke Therapeutics Product

Table 95. Merck Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 96. Merck Recent Development

Table 97. Zocere, Inc. Company Details

Table 98. Zocere, Inc. Business Overview

Table 99. Zocere, Inc. Stroke Therapeutics Product

Table 100. Zocere, Inc. Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 101. Zocere, Inc. Recent Development

Table 102. Acticor Biotech Company Details

Table 103. Acticor Biotech Business Overview

Table 104. Acticor Biotech Stroke Therapeutics Product

Table 105. Acticor Biotech Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 106. Acticor Biotech Recent Development

Table 107. DiaMedica Therapeutics Company Details

Table 108. DiaMedica Therapeutics Business Overview

Table 109. DiaMedica Therapeutics Stroke Therapeutics Product

Table 110. DiaMedica Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 111. DiaMedica Therapeutics Recent Development

Table 112. Lumosa Therapeutics Company Details

Table 113. Lumosa Therapeutics Business Overview

Table 114. Lumosa Therapeutics Stroke Therapeutics Product

Table 115. Lumosa Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 116. Lumosa Therapeutics Recent Development

Table 117. AXONIS Therapeutics , Inc. Company Details

Table 118. AXONIS Therapeutics , Inc. Business Overview

Table 119. AXONIS Therapeutics , Inc. Stroke Therapeutics Product

Table 120. AXONIS Therapeutics , Inc. Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 121. AXONIS Therapeutics , Inc. Recent Development

Table 122. NovaGo Therapeutics Company Details

Table 123. NovaGo Therapeutics Business Overview

Table 124. NovaGo Therapeutics Stroke Therapeutics Product

Table 125. NovaGo Therapeutics Revenue in Stroke Therapeutics Business (2020-2025) & (US$ Million)

Table 126. NovaGo Therapeutics Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

Table 130. Authors List of This Report

List of Figures

Figure 1. Stroke Therapeutics Picture

Figure 2. Global Stroke Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Stroke Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Intravenous Injection Features

Figure 5. Oral Features

Figure 6. Others Features

Figure 7. Global Stroke Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Stroke Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Ischemic Stroke Case Studies

Figure 10. Hemorrhagic Stroke Case Studies

Figure 11. Transient Ischemic Attack Case Studies

Figure 12. Stroke Therapeutics Report Years Considered

Figure 13. Global Stroke Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Stroke Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Stroke Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Stroke Therapeutics Market Share by Players in 2024

Figure 17. Global Top Stroke Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Stroke Therapeutics Revenue in 2024

Figure 19. North America Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Stroke Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Stroke Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Stroke Therapeutics Market Share by Region (2020-2031)

Figure 33. China Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Stroke Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Stroke Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Stroke Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Abbott Laboratories Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 49. Cordis Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 50. Boston Scientific Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 51. Siemens Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 52. Genentech Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 53. Koninklijke Philips Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 54. Medtronic Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 55. GE Healthcare Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 56. Stryker Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 57. Merck Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 58. Zocere, Inc. Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 59. Acticor Biotech Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 60. DiaMedica Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 61. Lumosa Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 62. AXONIS Therapeutics , Inc. Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 63. NovaGo Therapeutics Revenue Growth Rate in Stroke Therapeutics Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ischemic Cerebral Stroke Prevention Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cardiovascular Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cardiovascular Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Thrombolytic Treatment Market Research Report 2024

Cardiovascular Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mobile Stroke Treatment Unit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hemorrhagic Stroke Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Haemorrhagic Stroke Treatment Market Research Report 2025

Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stroke Prevention in Atrial Fibrillation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Image Guided Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intracranial Treatment Drug Market Research Report 2025

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Brain Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions